MICHAEL G. GREY - Director at Mirum Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
MIRM on Nasdaq
All Insider Reports
All Insider Reports

MICHAEL G. GREY - trading volume in the past year for Mirum Pharmaceuticals, Inc.

Holdings reported by MICHAEL G. GREY for Mirum Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 186,410 $13,632,163 $73.13 19 Dec 2025 By The Grey Family Trust dated November 12,1999
Common Stock 93,750 $6,855,937 $73.13 19 Dec 2025 By The Grey 2018 Irrevocable Children's Trust
Deferred Stock Units 3,977 $146,453 $25.68 29 May 2025 Direct Common Stock
Common Stock 0 $0 $78.00 19 Dec 2025 Direct
Stock Option (right to buy) 181,176 19 Dec 2025 Direct Common Stock

Transactions reported by MICHAEL G. GREY for Mirum Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.